NCT06087588 (PENG) is a Phase 4 clinical trial of 0.9%sodium chloride in Osteoarthritis, sponsored by Poznan University of Medical Sciences.

Who is sponsoring NCT06087588?

NCT06087588 is sponsored by Poznan University of Medical Sciences.

What drugs are being tested in NCT06087588?

Interventions in NCT06087588: 0.9%sodium chloride, 95% ethanol.

What condition does NCT06087588 study?

NCT06087588 studies Osteoarthritis, Osteoarthritis, Hip.

Is NCT06087588 still recruiting?

NCT06087588 is currently completed. Last updated 21 January 2025.

Last reviewed 2025-01-21 · How we verify

NCT06087588: PENG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

Completed Phase 4 Last updated 21 January 2025

What this trial tests

Phase 4 trial testing 0.9%sodium chloride in Osteoarthritis in 100 participants. Completed in 14 January 2025.

Timeline

17 October 2023

Primary endpoint
10 January 2025

14 January 2025

Quick facts

Lead sponsor	Poznan University of Medical Sciences
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	17 October 2023
Primary completion	10 January 2025
Estimated completion	14 January 2025
Sites	1 location across Poland

Drugs / interventions tested

0.9%sodium chloride
95% ethanol — full drug profile →

Conditions studied

Osteoarthritis — all drugs for Osteoarthritis →
Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →

Sponsor

Poznan University of Medical Sciences

Who can join

Adults 18 to 100, any sex, with Osteoarthritis or Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PENG neurolysis in advanced osteoarthritis of the hip joint.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial.
Reysner M, Reysner T, Kowalski G, Mularski A, et al · · 2025 · cited 1× · PMID 40480912 · DOI 10.1016/j.bja.2025.04.045

Verify or expand the search:

Other trials of 0.9%sodium chloride

Trials testing the same drug.

NCT07056582 — Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries · NA · recruiting
NCT06270407 — The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery · Phase 4 · recruiting
NCT06393530 — Erector Spinae Plane Block for Cervical Spine Surgery · Phase 4 · completed
NCT06233604 — Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty · Phase 4 · recruiting
NCT06233565 — Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery · Phase 4 · completed

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06087588 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
Last refreshed: 21 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06087588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing